Filing search / Phathom Pharmaceuticals, Inc. / "Materials"

Search information

Phathom Pharmaceuticals, Inc.

Companies

"Materials"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

80 results

Newest first Best match first

10-K

2024 FY

PHAT Phathom Pharmaceuticals, Inc.

Annual report

materials, which could adversely impact the timing of the commercial launch of the product. Fast Track designation, Breakthrough Therapy designation … and any amendments to those reports as soon as reasonably practicable after filing or furnishing such materials to the SEC. They are also available for free

6 Mar 25

8:05am

10-Q

2024 Q3

PHAT Phathom Pharmaceuticals, Inc.

Quarterly report

materials Total inventory, current Raw materials, non-current Total inventory Raw materials consist of materials, including active pharmaceutical

7 Nov 24

4:05pm

8-K

EX-1.1

PHAT Phathom Pharmaceuticals, Inc.

19 Aug 24

Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants

5:13pm

is authorized to disclose to any persons the U.S. federal and state income tax treatment and tax structure of the potential transaction and all materials

10-Q

2024 Q2

PHAT Phathom Pharmaceuticals, Inc.

Quarterly report

expenses Inventory consist of the following (in thousands): June 30, December 31, Finished goods Raw materials Total inventory, current Raw materials … , noncurrent Total inventory Raw materials consist of materials, including active pharmaceutical ingredients, to be consumed in the production of inventory

8 Aug 24

4:05pm

10-K/A

2023 FY

PHAT Phathom Pharmaceuticals, Inc.

Annual report (amended)

discounts and allowances Accrued other Total accrued expenses Inventory consist of the following (in thousands): December 31, Finished goods Raw materials … Total inventory, current Raw materials, noncurrent Total inventory Raw materials consist of materials, including active pharmaceutical ingredients

14 Jun 24

4:05pm

10-K/A

EX-10.27

3693mvfujk 9d8o

Annual report (amended)

14 Jun 24

4:05pm

10-Q/A

qal oj21vr4uy6

Quarterly report (amended)

14 Jun 24

4:05pm

10-Q

457tb7jh ym23s

Quarterly report

9 May 24

4:06pm

DEFA14A

qgax3e ow

12 Apr 24

Additional proxy soliciting materials

12 Apr 24

4:03pm

10-K

whv3p5x4p zgug

Annual report

7 Mar 24

4:01pm

7 Mar 24

4:01pm

Amendments to Articles of Incorporation or Bylaws

Amendments to Articles of Incorporation or Bylaws

9 Nov 23

8:05am

10-Q

c4wtvgz5pv2drvngvkg

Quarterly report

10 Aug 23

8:06am

8-K

mfchhdly44 4gmvoipoj

17 Jul 23

Departure of Directors or Certain Officers

Information about tender offer

Issuer tender offer statement

9:01am

Filing search / Phathom Pharmaceuticals, Inc. / "Materials"

80 results

Top filers

Top filing types

Recent filing years